{"id":228595,"date":"2026-01-08T21:20:09","date_gmt":"2026-01-09T03:20:09","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/01\/targeting-b-cells-enhances-sting-agonism-in-liver-cancer"},"modified":"2026-01-08T21:20:09","modified_gmt":"2026-01-09T03:20:09","slug":"targeting-b-cells-enhances-sting-agonism-in-liver-cancer","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/01\/targeting-b-cells-enhances-sting-agonism-in-liver-cancer","title":{"rendered":"Targeting B cells enhances STING agonism in liver cancer"},"content":{"rendered":"

<\/a><\/p>\n

The researchers used advanced laboratory and experimental models to uncover how B-cells contribute to immunotherapy resistance in liver cancer. Using liver cancer mouse models, they tested treatments that either blocked B-cells or targeted immune pathways.<\/p>\n

They found that when tumors stopped responding to immunotherapy, B-cells moved into the tumor and formed clusters that looked like special immune structures called tertiary lymphoid tissues.<\/p>\n

\u201cCombining B-cell depletion with immunotherapy (anti-PD-1 ICB or the STING agonist BMS-986301) significantly improved survival and reduced metastasis,\u201d said the author. \u201cThese exciting findings suggest that targeting B-cells or their signaling pathways could overcome acquired resistance and enhance the effectiveness of cancer immunotherapy, including in cases where the disease has spread.\u201d<\/p>\n

\n

Scientists have identified a promising strategy to improve liver cancer immunotherapy: targeting B-cells. While immunotherapy has transformed cancer treatment by activating T-cells\u2014a type of immune cell that fights cancerous cells\u2014many patients still fail to respond. New research shows that B-cells\u2014another type of immune cells that fight infections\u2014may play a surprising role in limiting immunotherapy\u2019s effectiveness.<\/p>\n

The study was recently published in Nature Communications.<\/i> The study<\/a>\u2019s principal investigator said that most current research efforts are focusing on activating T-cells against cancers. This study showed tumor-associated B-cells can create an environment that suppresses T-cell activity, allowing cancer cells to escape immune attacks.<\/p>\n

\u201cWe observed a significant rise in B-cell activity in the tumor, suggesting they may play an important role in how cancer escapes treatment,\u201d said the author. \u201cBy blocking these immunosuppressive B-cells, we may be able to remove this barrier and enhance the power of immunotherapy.\u201d<\/p>\n

Continue reading \u201cTargeting B cells enhances STING agonism in liver cancer\u201d | ><\/a><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"

The researchers used advanced laboratory and experimental models to uncover how B-cells contribute to immunotherapy resistance in liver cancer. Using liver cancer mouse models, they tested treatments that either blocked B-cells or targeted immune pathways. They found that when tumors stopped responding to immunotherapy, B-cells moved into the tumor and formed clusters that looked like [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-228595","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/228595","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=228595"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/228595\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=228595"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=228595"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=228595"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}